CA2161737A1 - Gel de metronidazole - Google Patents

Gel de metronidazole

Info

Publication number
CA2161737A1
CA2161737A1 CA2161737A CA2161737A CA2161737A1 CA 2161737 A1 CA2161737 A1 CA 2161737A1 CA 2161737 A CA2161737 A CA 2161737A CA 2161737 A CA2161737 A CA 2161737A CA 2161737 A1 CA2161737 A1 CA 2161737A1
Authority
CA
Canada
Prior art keywords
metronidazole
metronidazole gel
effective amount
gel
rosacea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2161737A
Other languages
English (en)
Other versions
CA2161737C (fr
Inventor
Richard J. Mackay
Jacques D. Bourgeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Canada Inc
Original Assignee
Stiefel Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Canada Inc filed Critical Stiefel Canada Inc
Priority to CA002161737A priority Critical patent/CA2161737C/fr
Publication of CA2161737A1 publication Critical patent/CA2161737A1/fr
Application granted granted Critical
Publication of CA2161737C publication Critical patent/CA2161737C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002161737A 1995-10-30 1995-10-30 Gel de metronidazole Expired - Lifetime CA2161737C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002161737A CA2161737C (fr) 1995-10-30 1995-10-30 Gel de metronidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002161737A CA2161737C (fr) 1995-10-30 1995-10-30 Gel de metronidazole

Publications (2)

Publication Number Publication Date
CA2161737A1 true CA2161737A1 (fr) 1997-05-01
CA2161737C CA2161737C (fr) 1998-10-20

Family

ID=4156874

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002161737A Expired - Lifetime CA2161737C (fr) 1995-10-30 1995-10-30 Gel de metronidazole

Country Status (1)

Country Link
CA (1) CA2161737C (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1206937A1 (fr) * 1999-07-16 2002-05-22 Shoei Co., Ltd. Preparations de nitroimidazole a usage externe pour traiter la dermatose
WO2002078666A1 (fr) * 2001-03-28 2002-10-10 Stiefel Laboratories, Inc. Tampons de metronidazole
DE102004004969A1 (de) * 2004-01-28 2005-08-18 Beiersdorf Ag Verwendung von UV-Lichtschutzfiltern in Anti-Akne-Zubereitungen
FR2866568A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter un desordre de la vascularisation cutanee
FR2866570A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2866569A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
US7357938B2 (en) 2001-07-09 2008-04-15 Stiefel Laboratories, Inc. Sulfacetamide formulations for treatment of rosacea
US20120258125A1 (en) * 2011-04-06 2012-10-11 Lancell, L.L.C. Method to identify a novel class of immunologic adjuvants
US8501202B2 (en) 2001-07-09 2013-08-06 Aqua Pharmaceuticals, Llc Sulfacetamide formulations for treatment of skin dermatoses

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1206937A1 (fr) * 1999-07-16 2002-05-22 Shoei Co., Ltd. Preparations de nitroimidazole a usage externe pour traiter la dermatose
EP1206937A4 (fr) * 1999-07-16 2005-01-19 Shoei Co Ltd Preparations de nitroimidazole a usage externe pour traiter la dermatose
WO2002078666A1 (fr) * 2001-03-28 2002-10-10 Stiefel Laboratories, Inc. Tampons de metronidazole
US8501202B2 (en) 2001-07-09 2013-08-06 Aqua Pharmaceuticals, Llc Sulfacetamide formulations for treatment of skin dermatoses
US7357938B2 (en) 2001-07-09 2008-04-15 Stiefel Laboratories, Inc. Sulfacetamide formulations for treatment of rosacea
DE102004004969A1 (de) * 2004-01-28 2005-08-18 Beiersdorf Ag Verwendung von UV-Lichtschutzfiltern in Anti-Akne-Zubereitungen
WO2005089750A2 (fr) * 2004-02-20 2005-09-29 Galderma Research & Development, S.N.C. Utilisation du metronidazole pour le traitement des pathologies liees au recepteur de type b de l’interleukine 8 et/ou recepteur de type 1 de pacap
WO2005089749A2 (fr) * 2004-02-20 2005-09-29 Galderma Research & Development, S.N.C. Utilisation du metronidazole pour le traitement d’ un desordre de la vascularisaton cutanee
FR2866569A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
WO2005089751A2 (fr) * 2004-02-20 2005-09-29 Galderma Research & Development, S.N.C. Utilisation du metronidazole pour le traitement d’une inflammation cutanee
WO2005089751A3 (fr) * 2004-02-20 2005-12-08 Galderma Res & Dev Utilisation du metronidazole pour le traitement d’une inflammation cutanee
WO2005089750A3 (fr) * 2004-02-20 2006-05-04 Galderma Res & Dev Utilisation du metronidazole pour le traitement des pathologies liees au recepteur de type b de l’interleukine 8 et/ou recepteur de type 1 de pacap
WO2005089749A3 (fr) * 2004-02-20 2006-05-04 Galderma Res & Dev Utilisation du metronidazole pour le traitement d’ un desordre de la vascularisaton cutanee
FR2866570A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2866568A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter un desordre de la vascularisation cutanee
US20120258125A1 (en) * 2011-04-06 2012-10-11 Lancell, L.L.C. Method to identify a novel class of immunologic adjuvants

Also Published As

Publication number Publication date
CA2161737C (fr) 1998-10-20

Similar Documents

Publication Publication Date Title
AU6664594A (en) Topical ultra-violet radiation protectants
AU669959B2 (en) Infeed plate for an axial agricultural combine
AU3634295A (en) Contrast enhancement by spatial histogram analysis
CA2168248A1 (fr) Solution antifongique pour les ongles
CA2230819A1 (fr) Medicament comprenant le gene hgf
AU5444096A (en) In-line check valve
AU9751898A (en) Composition for topical application on the skin and/or its appendages comprisingat least a compound containing an iminophenol fragment
AU6916694A (en) Novel treatments for allergic diseases
AU3677493A (en) Wideband arrayable planar radiator
AU7002296A (en) Analgesic composition
AU1353397A (en) Aqueous cross-linkable coating composition
AU5988896A (en) Topical composition for fungal treatment
AU2458297A (en) Gate valve
AU6410996A (en) Topical phenylephrine preparation
AU1117497A (en) Analgesic compounds and uses thereof
AU4542196A (en) New preservative composition
AU5395794A (en) 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1- carboxamide as an analgesic and anti-inflammatory agent
CA2267309A1 (fr) Utilisation de 1-hydroxy-2-pyridones pour le traitement d'infections cutanees
CA2161737A1 (fr) Gel de metronidazole
AU4094293A (en) Methods for the diagnosis of fungal infections
AU3060397A (en) Enhancement of the efficacy of fungicides
AU5900296A (en) Cycloalkane benzylidines as microbicides
AU1128997A (en) Topical retinoid composition
AU6337294A (en) Ophthalmic topical agent
AU5693596A (en) Active compound combinations

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20151030